HOLX - Hologic, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
40.16
-0.10 (-0.25%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close40.26
Open40.48
Bid39.35 x 900
Ask40.99 x 800
Day's Range39.57 - 40.53
52 Week Range35.10 - 45.17
Volume3,121,213
Avg. Volume2,095,238
Market Cap11.615B
Beta (3Y Monthly)1.09
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Benzinga5 days ago

    The Daily Biotech Pulse: Axovant In-Licenses 2 Gene Therapies, Agile To Undertake Additional Study Of Contraceptive Patch

    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting 52-week highs on Dec. 13) Kezar Life Sciences Inc (NASDAQ: KZR ) Down In The Dumps ...

  • Zacks5 days ago

    Hologic's (HOLX) New Offering to Revitalize Cynosure Division

    The latest launch along with certain new developments is expected to boost top-line contribution from Hologic's (HOLX) Cynosure division in the near term.

  • Is Hologic, Inc. (HOLX) A Good Stock To Buy?
    Insider Monkey5 days ago

    Is Hologic, Inc. (HOLX) A Good Stock To Buy?

    It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not gamble the hard-earned money of the people who are on the edge of poverty. Truth […]

  • See what the IHS Markit Score report has to say about Hologic Inc.
    Markit6 days ago

    See what the IHS Markit Score report has to say about Hologic Inc.

    Hologic Inc NASDAQ/NGS:HOLX

  • Simply Wall St.8 days ago

    Here’s What We Think About Hologic, Inc.’s (NASDAQ:HOLX) CEO Pay

    Steve MacMillan has been the CEO of Hologic, Inc. (NASDAQ:HOLX) since 2013. This report will, first, examine the CEO compensation levels in comparison to CEO compensation at other big companies. Read More...

  • Zacks8 days ago

    Hologic Unveils Omni Hysteroscope, Boosts GYN Surgical Arm

    Hologic (HOLX) highlights that a direct visualization of the uterine cavity in women with abnormal uterine bleeding will set a benchmark for the medical test.

  • See what the IHS Markit Score report has to say about Hologic Inc.
    Markit8 days ago

    See what the IHS Markit Score report has to say about Hologic Inc.

    Hologic Inc NASDAQ/NGS:HOLX

  • How Hologic Stock Has Fared in the Last Month
    Market Realist13 days ago

    How Hologic Stock Has Fared in the Last Month

    After rising from $36.53 on April 9, 2018, to $42.91 on July 31, 2018, Hologic (HOLX) stock slid to $37.90 on October 29, 2018. Subsequently, Hologic stock managed to rise to $44.51 on November 28, 2018. Hologic’s revenue grew by 1.32% from $802.9 million in the fourth quarter of 2017 to $813.5 million in the fourth quarter of 2018.

  • See what the IHS Markit Score report has to say about Hologic Inc.
    Markit15 days ago

    See what the IHS Markit Score report has to say about Hologic Inc.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.

  • 3 Big Stock Charts for Friday: Hologic, Newell Brands and Juniper Networks
    InvestorPlace19 days ago

    3 Big Stock Charts for Friday: Hologic, Newell Brands and Juniper Networks

    The 2.6% advance from General Electric (NYSE:GE) shares on Thursday still wasn’t enough to get, and keep, the overall market out of the red. Although the index spent some time in profitable territory yesterday, by the time the closing bell rang the S&P 500 was down to the tune of 0.22%. Rather than GE, a few too many traders were taking their cues from Twitter (NYSE:TWTR) and Quest Diagnostics (NYSE:DGX).

  • Analysts Remain Bullish on Align Stock
    Market Realist20 days ago

    Analysts Remain Bullish on Align Stock

    In November 2018, of the total 15 analysts covering Align Technology (ALGN), 13 analysts have given Align stock a “buy” or higher rating, and two analysts have given it a “hold” rating. The mean rating for Align Technology stock is 1.67 with a target price of $317.36, implying an upside potential of 43.8% over Align Technology’s closing price of $220.71 on November 27, 2018.

  • See what the IHS Markit Score report has to say about Hologic Inc.
    Markit22 days ago

    See what the IHS Markit Score report has to say about Hologic Inc.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.

  • What Analysts Recommend for Hologic Stock
    Market Realist23 days ago

    What Analysts Recommend for Hologic Stock

    In November 2018, of the total 20 analysts covering Hologic (HOLX), ten analysts have given the stock a “buy” or higher rating, and ten analysts have given it a “hold” rating. The mean rating for Hologic stock is 2.3 with a target price of $45.09, implying an upside potential of 8.5% over Hologic’s closing price of $41.54 on November 21, 2018.

  • How Does Hologic’s Operational Performance Look?
    Market Realist23 days ago

    How Does Hologic’s Operational Performance Look?

    Hologic (HOLX) incurred general and administrative expenses of $366.1 million in fiscal 2018 as compared with $343.3 million in fiscal 2017. This increase was due to higher legal fees, costs for international infrastructure, and higher bad debt. Its selling and marketing expenses also increased from $498.6 million in fiscal 2017 to $544.6 million in fiscal 2018 due to Cynosure’s inclusion in Hologic’s activity.

  • A Look at Hologic’s Gross Margin Trend
    Market Realist23 days ago

    A Look at Hologic’s Gross Margin Trend

    Hologic’s (HOLX) cost of product revenues increased from $881.8 million in fiscal 2017 to $886.6 million in fiscal 2018. Its amortization on intangible assets increased from $297.1 million in fiscal 2017 to $319.4 million in fiscal 2018 due to an increase associated with the Cynosure acquisition partially offset by lower amortization expenses related to the sale of its blood screening business. The company’s gross margin contracted from 64.07% in fiscal 2017 to 62.72% in fiscal 2018.

  • How Hologic’s Revenue Is Trending
    Market Realist23 days ago

    How Hologic’s Revenue Is Trending

    Hologic (HOLX) is a leading developer, manufacturer, and supplier of diagnostics products, medical imaging systems, surgical products, and treatment systems. The company operates in five segments: diagnostics, breast health, medical aesthetics, GYN surgical, and skeletal health.

  • See what the IHS Markit Score report has to say about Hologic Inc.
    Markitlast month

    See what the IHS Markit Score report has to say about Hologic Inc.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.

  • Thomson Reuters StreetEventslast month

    Edited Transcript of HOLX earnings conference call or presentation 7-Nov-18 9:30pm GMT

    Q4 2018 Hologic Inc Earnings Call

  • Hologic (HOLX) Q4 Earnings Miss, Revenues Top Estimates
    Zackslast month

    Hologic (HOLX) Q4 Earnings Miss, Revenues Top Estimates

    Tough year-over-year comparisons and soft Diagnostics sales hurt Hologic's (HOLX) performance in Q4.

  • Hologic, Inc. (HOLX) Q4 2018 Earnings Conference Call Transcript
    Motley Foollast month

    Hologic, Inc. (HOLX) Q4 2018 Earnings Conference Call Transcript

    HOLX earnings call for the period ending September 30, 2018.

  • Hologic (HOLX) Misses Q4 Earnings Estimates
    Zackslast month

    Hologic (HOLX) Misses Q4 Earnings Estimates

    Hologic (HOLX) delivered earnings and revenue surprises of -1.69% and 1.04%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Presslast month

    Hologic: Fiscal 4Q Earnings Snapshot

    MARLBOROUGH, Mass. (AP) _ Hologic Inc. (HOLX) on Wednesday reported fiscal fourth-quarter profit of $50.5 million. The Marlborough, Massachusetts-based company said it had profit of 18 cents per share. The results fell short of Wall Street expectations.